Lv2
140 积分 2023-11-16 加入
An interpretable machine learning model for prediction of significant liver fibrosis in comorbid chronic hepatitis B and nonalcoholic fatty liver disease: a retrospective development and validation study
6小时前
求助中
Getting to HBV cure—Will new biomarkers help?
11天前
已完结
Changes in HBcAg and HBsAg Expression Following Antiviral Therapy and Their Role in Outcome of Patients with Chronic Hepatitis B
11天前
已完结
Development and validation of a potential biomarker to improve the assessment of liver fibrosis progression in patients with chronic hepatitis B
4个月前
已完结
Risk predictive model for the development of hepatocellular carcinoma before initiating long‐term antiviral therapy in patients with chronic hepatitis B virus infection
4个月前
已完结
Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B
4个月前
已完结
A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD
4个月前
已完结
Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease
4个月前
已完结
Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B
6个月前
已完结
Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg‐positive patients with functional cure following PEG‐IFN‐based therapy
6个月前
已完结
皖公网安备34019202002308
